tradingkey.logo
tradingkey.logo
Search

Jade Biosciences Ord Shs

JBIO
Add to Watchlist
19.750USD
-0.250-1.25%
Close 07-31 16:00ETQuotes delayed by 15 min
1.20BMarket Cap
LossP/E TTM

JBIO Financials

See Jade Biosciences Ord Shs's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Jade Biosciences Ord Shs Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.57/-0.48
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-3.19
96.25%
Analyst Rating
STRONG BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Financial Indicators
EPS
---0.57
---0.50
---0.64
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
-1215.73%-33.13M
-392.49%-26.74M
-55.05%-25.18M
89.14%-2.52M
73.40%-5.43M
17.00%-16.24M
-30.22%-24.77M
-40.35%-23.19M
-35.89%-20.41M
-43.97%-19.56M
-58.66%-19.02M
-51.42%-16.52M
-82.20%-15.02M
-119.73%-13.59M
-107.31%-11.99M
-290.48%-10.91M
-115.89%-8.24M
-168.05%-6.18M
-162.67%-5.78M
-94.57%-2.79M
Operating profit
-1182.70%-43.45M
-446.29%-34.98M
-60.15%-27.40M
86.24%-3.39M
70.98%-6.40M
19.93%-17.11M
-28.66%-26.16M
-39.57%-24.62M
-39.20%-22.07M
-50.99%-21.37M
-66.48%-20.34M
-60.08%-17.64M
-91.73%-15.85M
-128.26%-14.15M
-111.55%-12.21M
-296.37%-11.02M
-125.72%-8.27M
-176.42%-6.20M
-255.32%-5.77M
-104.71%-2.78M
Net Profit
-1215.73%-33.13M
-392.49%-26.74M
-55.05%-25.18M
89.14%-2.52M
73.40%-5.43M
17.00%-16.24M
-30.22%-24.77M
-40.35%-23.19M
-35.89%-20.41M
-43.97%-19.56M
-58.66%-19.02M
-51.42%-16.52M
-82.20%-15.02M
-119.73%-13.59M
-107.31%-11.99M
-290.48%-10.91M
-115.89%-8.24M
-168.05%-6.18M
-162.67%-5.78M
-94.57%-2.79M
Current assets
311.66%318.52M
335.38%348.82M
122.24%201.36M
-25.05%77.37M
-35.51%80.12M
-34.15%90.61M
-27.36%110.76M
-14.37%103.24M
-5.52%124.23M
-5.20%137.60M
-0.64%152.47M
-27.32%120.57M
-24.57%131.50M
-20.72%145.16M
158.73%153.45M
1627.25%165.88M
--174.33M
--183.10M
--59.31M
--9.60M
Total current liabilities
822.30%22.29M
332.05%16.54M
116.74%22.36M
-84.42%2.42M
-78.30%3.83M
-29.95%10.31M
28.12%17.02M
45.89%15.52M
126.64%17.64M
91.11%14.72M
253.67%13.28M
126.17%10.64M
205.18%7.78M
101.44%7.71M
-10.42%3.76M
163.92%4.70M
--2.55M
--3.83M
--4.19M
--1.78M
Total assets
312.00%319.43M
335.42%349.78M
122.57%202.45M
-27.42%77.53M
-36.95%80.33M
-35.43%90.96M
-28.29%111.69M
-14.13%106.82M
-5.83%127.42M
-4.59%140.88M
0.05%155.75M
-25.51%124.39M
-22.85%135.30M
-19.81%147.66M
149.36%155.68M
1578.72%167.00M
--175.36M
--184.13M
--62.43M
--9.95M
Total liabilities
823.64%22.97M
342.87%17.26M
120.75%23.10M
-84.38%2.49M
-78.30%3.90M
-30.93%10.47M
25.07%17.30M
40.88%15.92M
109.89%17.96M
77.89%15.15M
198.62%13.83M
123.63%11.30M
190.59%8.56M
99.16%8.52M
10.51%4.63M
183.50%5.05M
--2.94M
--4.28M
--4.19M
--1.78M
Total equity
295.04%296.46M
335.04%332.52M
122.81%179.35M
-17.44%75.05M
-30.17%76.43M
-35.98%80.49M
-33.49%94.40M
-19.62%90.90M
-13.64%109.46M
-9.64%125.72M
-6.04%141.93M
-30.17%113.09M
-26.49%126.74M
-22.64%139.14M
159.35%151.05M
1883.19%161.95M
--172.42M
--179.85M
--58.24M
--8.17M
Net operating income
-911.38%-24.08M
-204.60%-33.65M
-37.90%-22.12M
89.94%-2.38M
25.36%-11.05M
-2.77%-16.04M
-36.74%-20.43M
-107.22%-23.67M
0.44%-14.80M
-60.61%-15.61M
-68.35%-14.94M
-101.80%-11.42M
-13.53%-14.87M
-48.94%-9.72M
-121.62%-8.88M
-49.96%-5.66M
-353.99%-13.09M
-168.23%-6.53M
-194.70%-4.00M
-219.10%-3.77M
Net investment
-165.91%-8.47M
-847.67%-98.16M
-1025.55%-148.71M
45.48%12.85M
132.45%13.13M
222.37%16.07M
351.92%18.00M
-42.55%8.83M
-61.01%5.65M
-382.67%-13.13M
-51.39%3.98M
175.37%15.38M
112.78%14.49M
8394.64%4.64M
--8.19M
-50897.50%-20.40M
---113.34M
---56.00K
--0.00
---40.00K
Net financing
---795.00K
30614.80%170.16M
-100.00%0.00
----
19.65%554.00K
10.00%22.00K
-46.17%24.38M
111.21%471.00K
29.69%463.00K
-45.95%20.00K
2264400.00%45.29M
--223.00K
242.80%357.00K
-99.97%37.00K
-100.00%2.00K
-100.00%0.00
---250.00K
1338.78%128.31M
--54.51M
--7.88M

FAQs

What are the current assets of Jade Biosciences Ord Shs?

According to Jade Biosciences Ord Shs's FY2025 earnings report, its current assets were 348.82M, with a year-on-year change of 335.38.

What are the total assets of Jade Biosciences Ord Shs?

According to Jade Biosciences Ord Shs's FY2025 earnings report, its total assets of Jade Biosciences Ord Shs were 349.78M, with a year-on-year change of 335.42.

What are the total liabilities of Jade Biosciences Ord Shs?

According to Jade Biosciences Ord Shs's FY2025 earnings report, its total liabilities of Jade Biosciences Ord Shs were 17.26M, with a year-on-year change of 342.87.

What is the total equity of Jade Biosciences Ord Shs?

According to Jade Biosciences Ord Shs's FY2025 earnings report, its total equity of Jade Biosciences Ord Shs was 332.52M, with a year-on-year change of 335.04.

What is the net operating income of Jade Biosciences Ord Shs?

According to Jade Biosciences Ord Shs's FY2025 earnings report, its net operating income of Jade Biosciences Ord Shs was -113.54M, with a year-on-year change of -52.82.

What is the net investment of Jade Biosciences Ord Shs?

According to Jade Biosciences Ord Shs's FY2025 earnings report, its net investment of Jade Biosciences Ord Shs was -247.01M, with a year-on-year change of -540.85.

What is the net financing of Jade Biosciences Ord Shs?

According to Jade Biosciences Ord Shs's FY2025 earnings report, its net financing of Jade Biosciences Ord Shs was 360.77M, with a year-on-year change of 1318.84.

What is the Earnings Per Share (EPS) of Jade Biosciences Ord Shs?

According to Jade Biosciences Ord Shs's FY2025 earnings report, its Earnings Per Share (EPS) was -3.19, with a year-on-year change of 96.25.

What is the net income of Jade Biosciences Ord Shs?

According to Jade Biosciences Ord Shs's FY2025 earnings report, its net income was -100.14M, with a year-on-year change of -43.82.

What is the Return on Equity (ROE) of Jade Biosciences Ord Shs?

According to Jade Biosciences Ord Shs's FY2025 earnings report, its Return on Equity (ROE) was -48.97, with a year-on-year change of 34.63.

What is the Return on Assets (ROA) of Jade Biosciences Ord Shs?

According to Jade Biosciences Ord Shs's FY2025 earnings report, its Return on Assets (ROA) was -59.24, with a year-on-year change of 11.62.

What is the operating profit of Jade Biosciences Ord Shs?

According to Jade Biosciences Ord Shs's FY2025 earnings report, its operating profit was -113.54M, with a year-on-year change of -52.82.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.